Clinical trial · Interventional
MOST EMPOWER: Optimizing An Emotion Regulation Intervention
Using MOST to EMPOWER: Optimizing an Emotion Regulation Intervention to Enhance Well-being Among Adolescents and Young Adult Cancer Survivors
NCT04317417CI-TRIAL-00117455MOST EMPOWERcompletedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This purpose of this study is to test a digital health intervention that may promote well-being among young adult cancer survivors. Investigators hope to learn more about wellness and health-related quality of life among young adult cancer survivors by promoting well-being and teaching skills for healthy coping and mood management.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EMPOWER | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (32)
- type
- EXPERIMENTAL
- label
- Arm 1 No PE, No M, No PR, No PS, No AK
- interventionNames
- Behavioral: EMPOWER
- type
- EXPERIMENTAL
- label
- Arm 2 No PE, No M, No PR, No PS, Yes AK
- interventionNames
- Behavioral: EMPOWER
- type
- EXPERIMENTAL
- label
- Arm 3 No PE, No M, No PR, Yes PS, No AK
- interventionNames
- Behavioral: EMPOWER
- type
- EXPERIMENTAL
- label
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: * Able to read and understand English * Past history of a cancer diagnosis (excluding basal cell skin carcinoma) * 15 to 39 years of age at diagnosis of first cancer and currently between the ages of 15 to 39 * Within 0-5 year's post-active treatment for initial diagnosis or recurrence (Note: Maintenance therapy for hematologic or hormonal therapy for breast cancers are not considered "active treatments" for purposes of this study). * Internet access through a home computer, tablet or smartphone. Exclusion Criteria: * Ever been hospitalized for a psychiatric illness * Currently receiving palliative or hospice care
References
Publications (1)
- DERIVEDSalsman JM, Murphy KM, Addington EL, Tooze JA, McLouth LE, Yang D, Sanford S, Wagner L, Bunch SC, Rosenberg AR, Valle CG, Zebrack B, Howard D, Roth M, Moskowitz JT. Optimization of a digital health intervention to enhance well-being among adolescent and young adult cancer survivors: Design and methods of the EMPOWER full factorial trial. Contemp Clin Trials. 2025 Feb;149:107783. doi: 10.1016/j.cct.2024.107783. Epub 2024 Dec 20. PMID 39710338